Drug shortage
Extended Release · Mylan Pharmaceuticals Inc., a Viatris Company
FDA drug shortage · To Be Discontinued · updated Feb 26, 2025
Key facts
| Generic name | Extended Release, Tolterodine Tartrate Capsule |
|---|---|
| Company | Mylan Pharmaceuticals Inc., a Viatris Company |
| Presentation | Detrol LA, Capsule, Extended Release, 4 mg (NDC 58151-104-93) |
| Dosage form | Capsule, Extended Release |
| Status | To Be Discontinued |
| Therapeutic category | Urology |
| Package NDCs | 58151-104-93 |
| First posted | Feb 26, 2025 |
| Last updated | Feb 26, 2025 |
| Discontinued | Feb 26, 2025 |
At a glance
- 1–9 Package NDCs affected
- 100–999 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: